Cabaletta Bio, Inc. Common Stock (CABA) is a publicly traded Healthcare sector company. As of May 21, 2026, CABA trades at $3.44 with a market cap of $536.45M and a P/E ratio of -1.62. CABA moved +5.20% today. Year to date, CABA is +56.36%; over the trailing twelve months it is +82.98%. Its 52-week range spans $0.99 to $5.46. Analyst consensus is strong buy with an average price target of $13.94. Rallies surfaces CABA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CABA combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $3.44 |
| Market Cap | $536.45M |
| P/E Ratio | -1.62 |
| EPS | $-2.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.46 |
| 52-Week Low | $0.99 |
| Volume | 588 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-167.86M |
| Gross Margin | 0.00% |
8 analysts cover CABA: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $13.94.